Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

13.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.6K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

108
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
108
Human Virome01:26

Human Virome

44
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
44

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From biology to biotechnology: Host-regulation factors from parasitoid wasps are a source of bioactive molecules with translational potential.

Insect molecular biology·2026
Same author

Spider venom peptides Ht1a and Gg1a are toxic to honeybee parasite <i>Varroa destructor</i> by topical application.

npj drug discovery·2026
Same author

A minimally invasive, scalable and reproducible neonatal rat model of severe focal brain injury.

Brain communications·2026
Same author

Venom proteome of the monophagous spider Ammoxenus amphalodes: a potential source of termite-specific toxins.

Insect biochemistry and molecular biology·2026
Same author

Glycaemic variability underlies myocyte dysfunction and myocardial injury risk in diabetes.

Nature communications·2026
Same author

Correction: The cytotoxicity of gomesin peptides is mediated by the glycosphingolipid pathway and lipid-cholesterol interactions.

Cell death discovery·2026

Related Experiment Video

Updated: Apr 20, 2026

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

34.9K

Spider venomics: implications for drug discovery.

Sandy S Pineda1, Eivind A B Undheim, Darshani B Rupasinghe

  • 1Institute for Molecular Bioscience, University of Queensland, Queensland, Australia.

Future Medicinal Chemistry
|November 19, 2014
PubMed
Summary
This summary is machine-generated.

Spider venoms contain stable, potent peptides with therapeutic potential. These natural toxins are being explored for drug discovery pipelines targeting pain, stroke, and cancer treatments.

More Related Videos

High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli
12:16

High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli

Published on: July 30, 2014

25.1K
Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
05:27

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production

Published on: October 6, 2023

4.8K

Related Experiment Videos

Last Updated: Apr 20, 2026

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

34.9K
High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli
12:16

High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli

Published on: July 30, 2014

25.1K
Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
05:27

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production

Published on: October 6, 2023

4.8K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Spiders have evolved complex venoms over 300 million years, utilizing toxins for survival.
  • Spider venoms primarily consist of small, stable disulfide-bridged peptides resistant to degradation.
  • These peptides exhibit high specificity and potency against therapeutically relevant molecular targets.

Purpose of the Study:

  • To review recent advancements in drug discovery pipelines utilizing spider venom components.
  • To highlight spider venom-derived peptides currently under investigation for various medical conditions.

Main Methods:

  • Literature review of current research on spider venom peptides.
  • Analysis of drug discovery pipelines focusing on spider venom components.
  • Identification of pathologies targeted by spider venom-derived therapeutics.

Main Results:

  • Spider venom peptides are valuable pharmacological tools due to their bioactivity and stability.
  • Numerous spider venom peptides show promise for therapeutic applications.
  • Ongoing research focuses on peptides for treating pain, stroke, and cancer.

Conclusions:

  • Spider venom peptides represent a rich source for novel drug development.
  • The unique properties of these peptides facilitate their use in modern drug discovery.
  • Further investigation into spider venom holds significant potential for treating diverse human diseases.